At Gilead, our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. Jointly reporting to the Commercial and Development Therapeutic Area Heads, the Gilead Asset Team Leader (GATL) is an enterprise leader responsible for leading the cross-functional asset team and shaping the asset vision, strategic direction, and lifecycle plan (LCP) including multiple indications and drug combinations. Serving as the primary liaison for senior leadership within the governance model, the GATL drives collaboration across Gilead, engaging diverse stakeholders involved in the development, manufacturing, and commercialization of an asset, to ensure optimal program execution in alignment with the asset strategy and the LCP. This senior role requires a diverse set of experiences across Development and Commercialization functions and relies on a record of achievement for optimizing asset outcomes. This role demands adept navigation of complex programmatic challenges and excellent enterprise-level leadership. As an Executive Director, Asset Team Leader, at Gilead you will be the Strategic Asset Leader and oversee the Overall Development Strategy for multiple molecules (typically 4-5 programs) in biologics. They will oversee and develop the Early Portfolio strategy within the biologic modality for molecules from Early Development Phase I to Proof of Concept.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive